This site uses cookies. By continuing to browse this site you are consenting to our use of cookies. For more information see our cookies policy.

Our cardiovascular disease programme Bradford’s Healthy Hearts (BHH) has been operational since 2015 and we are seeing some extremely positive results, including optimised treatment for 21,000 people and over 200 fewer people suffering heart attacks or strokes. 

The project has been recognised regionally, and Dr Youssef Beaini, Clinical Lead for Cardiovascular Disease (CVD) for the CCG is leading this work to support roll out across West Yorkshire and Harrogate with a focus on hypertension (high blood pressure) Atrial Fibrillation (AF – an irregular heart beat) and cholesterol. The aim of this programme is to reduce the number of people who experience a cardiovascular disease incident by 10% across the area by 2021. This would mean over 1,100 fewer CVD incidents, consisting of an estimated reduction of 350 strokes and 800 heart attacks. In addition we have gained national recognition with the recently published NHS Right Care case study

Bradford Healthy Hearts is also running a project funded by the British Heart Foundation to identify, through community testing, individuals who may have hypertension and encourage them to make an appointment with their GP for further diagnostics and treatment as appropriate.  Funding is for two years and we have commissioned HALE, one of our community providers to undertake the testing in local areas with the results recorded on the patient’s medical record.  Following the success of the hypertension project we are expanding the service to include testing for Atrial Fibrillation.

To date we have tested 300 people and identified almost half as being at increased risk of having high blood pressure, this result is inline with what NICE guidance expects to see. So far feedback from people tested has been very positive and this kind of “softer” intelligence will be shared as part of the project evaluation.

Through the programme we have reduced non-elective cardiovascular admissions by 10%.

We have prevented 74 strokes and 137 heart attacks.